Cardiovascular Research Advance Access [Accepted Manuscript] published online on March 18, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn078
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential Interactions of Thin Filament Proteins In Two Cardiac Troponin T Mouse Models of Hypertrophic and Dilated Cardiomyopathies


Center for Cardiovascular Genetics, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center and Texas Heart Institute, Houston, TX 77030
Section of Cardiology, Baylor College of Medicine, Houston, TX 77030
¶ University of Ottawa Heart Institute, Ottawa, Canada
Address for Correspondence and Reprints: AJ Marian, M.D. The Brown Foundation Institute of Molecular Medicine The University of Texas Health Sciences Center 6770 Bertner Street, Suite C900A Houston, TX 77030 Phone: 713 500 2350 (direct) and 713 500 2345 and 713 500 2312 (Indirect) Fax: 713 500 2320 Ali.J.Marian{at}uth.tmc.edu
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM), the opposite ends of spectrum of phenotypic responses of the heart to mutations. We posit the contracting phenotypes could result from differential effects of the mutant proteins on interactions among the sarcomeric proteins. To test the hypothesis, we generated transgenic mice expressing either cardiac troponin T (cTnT)-Q92 or cTnT-W141, known to cause HCM and DCM, respectively, in the heart.
Methods: We phenotyped the mice by echocardiography, histology and immunoblotting and RT-PCR. We detected interactions between the sarcomeric proteins by co-immunoprecipitation and determined Ca2+ sensitivity of myofibrillar protein ATPase activity by Carter assay.
Results: The cTnT-W141 mice exhibited dilated hearts and decreased systolic function. In contrast, the cTnT-Q92 mice showed smaller ventricles and enhanced systolic function. Levels of cardiac troponin I, cardiac
-actin,
-tropomyosin and cardiac troponin C co-immunoprecipitated with anti-cTnT antibodies were higher in the cTnT-W141 than in the cTnT-Q92 mice, as were levels of
-tropomyosin co-immunoprecipitated with an anti-cardiac
-actin antibody. In contrast, levels of cardiac troponin I co-immunoprecipitated with an anti-cardiac
-actin antibody were higher in the cTnT-Q92 mice. Ca2+ sensitivity of myofibrillar ATPase activity was increased in HCM but decreased in DCM mice as compared to non-transgenic mice.
Conclusions: Differential interactions among the sarcomeric proteins containing cTnT-Q92 or cTnT-W141 are responsible for the contrasting phenotypes of HCM or DCM, respectively.
Time for primary review: 22 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Lombardi, J. Dong, G. Rodriguez, A. Bell, T. K. Leung, R. J. Schwartz, J. T. Willerson, R. Brugada, and A. J. Marian Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy Circ. Res., May 8, 2009; 104(9): 1076 - 1084. [Abstract] [Full Text] [PDF] |
||||
